BZPEERPapers, people, evidence and research paths
Menu

Discover

SearchFind papers, people, topics, institutions and opportunities from one place.GraphSee how papers, authors, topics and evidence connect.

Research tools

HomeContinue from the papers, people and topics that matter now.CollectionsTurn saved papers into reading lists, evidence maps and shareable context.ResearchReconstruct the path that led you from search to paper to question.CollaborationMove from a paper, topic or expert request into a focused thread.PublishCreate full-text research articles with metadata, formulas and versions.

Network

ExpertsFind specialists whose work and reviews explain why they can help.CommunitiesJoin research groups organized around papers, topics and shared evidence.

Opportunities

ListingsBrowse roles, calls and collaborations connected to real research context.

Account

Log inReturn to your saved papers, graph views and active threads.Create accountStart saving papers, building a research trail and joining teams.
Log inCreate account

Source author record

Pantelis Georgiou

Pantelis Georgiou appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record
cs.CYeess.SPHuman-Computer InteractionMachine LearningQuantitative Methods

Catalog footprint

What is connected

2works
5topics
4close collaborators

Actions

Connect this record

Log in to claim
Open graphBrowse works

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

A novel hand-held interface supporting the self-management of Type 1 diabetes

The paper describes the interaction design of a hand-held interface supporting the self-management of Type 1 diabetes. It addresses well-established clinical and human-computer interaction requirements. The design exploits three opportunities. One is associated with visible context, whether conspicuous or inconspicuous. A second arises from the design freedom made possible by the user's anticipated focus of attention during certain interactions. A third opportunity to provide valuable functionality arises from wearable sensors and machine learning algorithms. The resulting interface permits ``What if?'' questions: it allows a user to dynamically and manually explore predicted short-term (e.g., 2 hours) relationships between an intended meal, blood glucose level and recommended insulin dosage, and thereby readily make informed food and exercise decisions. Design activity has been informed throughout by focus groups comprising people with Type 1 diabetes in addition to experts in diabetes, interaction design and machine learning. The design is being implemented prior to a clinical trial.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Basal Glucose Control in Type 1 Diabetes using Deep Reinforcement Learning: An In Silico Validation

People with Type 1 diabetes (T1D) require regular exogenous infusion of insulin to maintain their blood glucose concentration in a therapeutically adequate target range. Although the artificial pancreas and continuous glucose monitoring have been proven to be effective in achieving closed-loop control, significant challenges still remain due to the high complexity of glucose dynamics and limitations in the technology. In this work, we propose a novel deep reinforcement learning model for single-hormone (insulin) and dual-hormone (insulin and glucagon) delivery. In particular, the delivery strategies are developed by double Q-learning with dilated recurrent neural networks. For designing and testing purposes, the FDA-accepted UVA/Padova Type 1 simulator was employed. First, we performed long-term generalized training to obtain a population model. Then, this model was personalized with a small data-set of subject-specific data. In silico results show that the single and dual-hormone delivery strategies achieve good glucose control when compared to a standard basal-bolus therapy with low-glucose insulin suspension. Specifically, in the adult cohort (n=10), percentage time in target range [70, 180] mg/dL improved from 77.6% to 80.9% with single-hormone control, and to $85.6\%$ with dual-hormone control. In the adolescent cohort (n=10), percentage time in target range improved from 55.5% to 65.9% with single-hormone control, and to 78.8% with dual-hormone control. In all scenarios, a significant decrease in hypoglycemia was observed. These results show that the use of deep reinforcement learning is a viable approach for closed-loop glucose control in T1D.

0 citations0 reviewsNo code linkedOpen access